• Home
  • Investors
    • News Archive
    • Share Information
      • Shareholder Service
      • General Meetings
    • Reports
    • Board and Management
  • Contact

You are here

Home » Investors

News

Trading exclusive of subscription rights as of today
Extraordinary general meeting held in NorDiag ASA
NorDiag ASA CE IVD labels its high throughput instrument (Bullet)
Calendar of Finance 2009
Proposal for rights issue etc.
Notice of extraordinary general meeting in NorDiag ASA
Successful completion of NorDiag's clinical trial tailored to the BD Probetec (TM) ET system
NorDiag Q3: Successful outcome of clinical trial
Roche Diagnostics Scandinavia AB and NorDiag ASA sign new collaboration agreement
Successful completion of STI clinical trial for NorDiag`s `Bullet` Automated Sample Preparation Instrument
NorDiag ASA announces new agreement with Spartan Bioscience
Invitation to presentation of the 3rd quarter 2008
Distribution agreements and collaboration agreement with Molzym GmbH
Børsmelding fra Novel Diagnostics vedrørende NorDiag
NorDiag receives international prize
Oslo Børs - Re. last traded price
NorDiag Presentation DnB Health Care Summit 2008
Innovation Norway grants NorDiag risk loan of NOK 4 million
Market Making Agreement
NorDiag Q2-2008: Prototype of new cancer test completed

Pages

  • « first
  • ‹ previous
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • next ›
  • last »
News archive

NORDA ASA  ♦  P.O. Box 1666 Vika  ♦   0110 Oslo  ♦   Norway  ♦   Phone: +47 92 42 35 61  ♦   web: www.nordasa.no